NeedforRestructuring
Achievegrowth andsurvive GainBetter Competitive Position Focusoncore activities Achieve economiesof scale FundsRaising Utilizationof Excesscash
TaxPlanning& Costreduction
Bailouttakeover
Diversificationand Undiverisification
FamilySeparation
ReasonsforCarvingOutAlcon
Markettoreflect thefullvalueof Alcon Onlyfoodand beverageanalysts followNestlegroup Pharmaceutical Analystdonot considerAlcon beingpartofNestle Tocomeout conglomerate discount
UnbundlingtheValueofNestle
Food and Beverage (F&B) Industry EBITDA %F&B Enterprise Company Industry Value EBITDA Multiples Cadbury Schweppes 51% 15,518 1,511 10.3 Campbell 91% 16,254 1,475 11.0 Danone NA 21,854 2,138 10.2 General Mills 100% 28,104 1,484 18.9 Heinz 100% 19,855 1,912 10.4 Kellog 100% 18,262 1,640 11.1 Kraft 100% 33,082 6,608 5.0 Nestle 94% 97,500 7,662 12.7 Unilever NA 50,038 NA NA Mean 11.2 Median 10.7
Pharma Company % Pharma Enterprise EBITDA Company Industry Value EBITDA Multiples Allergan 63% 9,728 434 22.4 Bausch & Lomb** 15% 2,150 222 King 86% 10,429 426 24.5 Teva 88% 8,345 448 18.6 Forest 100% 14,128 449 31.5 Mean 24.2 Median 23.4
** Not included in analysis because only 15% of its business is in pharmaceuticals
96
UnbundlingtheValueofNestle
Valuation of Nestle's Parts Enterprise EBITDA Value EBITDA Multiples Nestle F&B 78,249.25 6,978.70 11.2 L'Oreal 9,100.00 NA Alcon 16,568.09 683.3 24.2 Ex. 9 (EBITDA of 2 000) Nestle 103,917.34 7,662.00 13.6
Nestl'sActualmarketmultiple(EBITDAMultiple)=12.7 Discountinvalue=103,917.34 (12.7*7662)=US$6609.94Millions
97
WhatistheParticipationofAlconin Group?
5%ofsales 12%ofEBIT
twicetheNestle groupsgrowthrate
WhyEquityCarveOut?
Spinoffs
SplitOff
Equity CurveOut
Restructuring
SplitUps
Divestitures
Tracking Stock
99
Spinoffs
Spinoffoftenfollowstheinitialsaleofup to20%ofthesharesinaninitialpublic offering(IPO) transactionknownasan equitycarveout EquityCurve Out Creationofsubsidiaryallowsparent toseparateriskofsubsidiary businessfromitscoreoperations shareholdersdecidewhetherto increaseordecreasetheirownrisk
SplitOff
Restructuring
SplitUps
Divestitures
Tracking Stock
100
SpinOffs
Stage1
Parent Firm ParentFirm Shareholders
Stage2
Parent Firm ParentFirm Shareholders
Subsidiary
101
SplitOff
EquityCurve Out
Restructuring
Compensationoftrackingcompany's managerscanbebasedonfinancial resultsandstockpriceoftrackingstock
SplitUps
Divestitures
Tracking Stock
102
TrackingStocks
TrackingStocks Issuedbythe ParentFirm
Parent Firm Parent Common Sub 1 Tracking Stock Sub 2 Tracking Stock Sub 3 Tracking Stock
Subsidiary 1
Subsidiary 2
Subsidiary 3
103
Needfor
Spinoffs
SplitOff
EquityCurve Out
Restructuring
SplitUps
Divestitures
Tracking Stock
Bringmorefocus Avoidoverlapofcapabilities Improvevaluationmultiplesforcore business Attempttoimproveshareprice Separatepoorperformers Resultedintakeover Subsidiarytruevaluehidden Preferenceforpureplay(singleindustry) securities Increasedavailabilityofinformation Management'sinabilitytomanage complexorganizations Selloffssharpenfocus,getridofpoorfit subsidiaries,eliminatenegativesynergy
SplitOff
EquityCurve Out
Restructuring
Frequentlyusedwhenaparent ownsalessthan100%investment stakeinasubsidiaryinorderto reducepressureonthespunoff firmsshareprice,because shareholderswhoexchangetheir stockarelesslikelytosellthenew stockand
SplitUps
Divestitures
Tracking Stock
105
SplitOff
Stage1
Parent Stock Subsidiary Stock Subsidiarystock nowheldbyformer parentshareholders. Parenthasno relationshipwithformer subsidiary Subsidiary Independent ofFormer Parent
Stage2
Former ParentFirm Shareholders
Parent Firm
ParentFirm Shareholders
Parent Firm
Subsidiary
Spinoffs
Motives
SplitOff EquityCurve Out
Restructuring
SplitUps
Divestitures
Tracking Stock
Deconglomeration Movingawayfromthecore business Assetsareworthmoretothe buyerthantotheseller Satisfyinggovernment requirements Correctingpastmistakes Assetshavebeeninterfering withprofitableoperationof otherbusinesses
107
Divestiture
Proceed to Negotiated Settlement Reactive Sale Pursue Alternative Bidders Potential Seller Public Sale or Auction Proactive Sale Private One on One or Controlled Sale Public Sale or Auction Private One on One or Controlled Sale Sequenceofevents: 1.Qualifiedbidderssignnondisclosure /receiveprospectus 2.Submissionofnonbindingbids expressedasrange 3.Bidsrankedbyprice,financing ability,formofpayment,formof acquisition;andeaseofdeal 4.Bestandfinaloffers
108
Spinoffs
SplitOff
Restructuring
SplitUps
Divestitures
Tracking Stock
109
Motivation
Marketforcorporatecontrol Assetare morevaluabletoalternativemanagement team Unlockinghiddenvalue Improvingmanagementincentives Managingagencycosts Divisionnolongerhasastrategicfit Returningtothecorebusiness Undiversifying Buyersmightsimplybewillingtopaytoo much Settingupasubsequentcontroltransaction Threatofacquisition Superiorperformancemeasurement Reductioninbureaucracy Tax/regulatoryfactors Bondholderwealthexpropriation Ifsellingnewlyissuedsubshares,thennon taxableandIfsellingsharesownedby parent,thentaxableongain!
110
Spinoffs
SplitOff
EquityCurve Out
Restructuring
SplitUps
Divestitures
Tracking Stock
EquityCarveOuts
InitialPublicOffering PrivateFirmSells APortionofItsEquity tothePublic SubsidiaryEquityCarveOut ParentFirmSells APortionofIts SubsidiaryStock tothePublic Cash Public/Private EquityMarkets
Stock
Cash
Subsidiary Stock
Public/Private EquityMarkets
Subsidiaryof ParentFirm
111
PossibleAlternatives
US
Switzerland
MovetoUS.,becomeaUS corporationandlistinUS
3
Nestle
ListinZurich
1
Alcon
4
138
PossibleAlternatives
US
Switzerland
Advantages ReincorporateAlconasaUSbasedsubsidiary KeepHQs,topmanagement,andR&Dfacilitiesin Texas FromUS revenues:53%andoperatingincome: 58% MoveAlcontoUSandincorporateitasaUSfirm ListinNewYork Sensibleoption Alconsoperationsanditsnatural investorbasearemainlyUSbased Disadvantages FullysubjecttoUScorporateincometax NotabletoclaimdeductionsinUSforroyalty paymentspaidtoSwissparentcompany Managementsignaledthatthisisnotanoption NestlewouldnotmoveAlconoutofSwitzerland RenamethefirmAlcon,Inc.ratherthanAlcon.AG., Amendtheincorporationdocumentationtoconform toUSstandardswhereverpossible Createaboardofdirectors,withprominent independentUSbusinessfigures;structurethe boardtoresembleotherUSboardswith characteristicssuchasstaggeredterms RegularlyquarterlyreportingofearningsunderUS GAAP DividendpaymentsinUSDbyestablishingahedging facilityconvertingdividendsdeclaredinSwissFrancs 139 intodollardenominatedpayments
3
Nestle
1
Alcon
PossibleAlternatives
US
Switzerland
3
Nestle
Advantages SimpletoIPOAlconinZurich SwisssubsidiaryofanotherSwiss company AlreadyoperatedunderSwiss securitieslaws Wouldsimplifyrelationsbetween NestleandAlcon Minimizefutureadministrativecosts ofoutstandingcommonshares WouldlimitNestleandits underwriterstothepoolofcapitalin Switzerland Switzerlandisadevelopedmarket withfewrestrictions Disadvantages USinvestorshavetodealinforeign currencyincurringhighertransaction costsmakingthesharelessattractive USpensionandMFsarerestricted frombuyingforeignshares LimitAlconsinvestorsbase
140
1
Alcon
PossibleAlternatives
US
Switzerland
3
Nestle
Advantages Avoidspotentialproblemofflowback sinceAlconssharestradedonlyin NewYork Alconwillbeabletofullyenjoythe benefitsofbeingaUSfirmwitha primarylistinginNewYorkwithout anyofthedrawbacksof reincorporatingasaUSfirm Helptargetspecialtypharmaceutical investors Disadvantages Accountingstandardsanddisclosure rules Efficiencyofbusinesspractices Governanceconcerns Legalregimes Transactioncosts ForcedtoabidebyUSaswellasSwiss securitieslaws notalwaysconsistent witheachother Tradingnormallyseemedtocenteron onemarket,eveniftheshareswere initiallyintroducedintwoplaces
141
1
Alcon
PossibleAlternatives
US
Switzerland
3
Nestle
1
Alcon
Advantages Mostfamiliarinstrument MaybetargetedbyUSpharma funds Maybeseenascandidateforinternationaldiversifications Minimizescrossnationaldifferencesinsecuritiesregulations andtradingconventions ListedonNYSE,AMEX,andNASDAQ Formofequityownership IssuedagainstsharesrepresentedthroughADS Canbeissuedformorethanoneunderlyingshareorfora fractionofshare ADRratio Reversibleprocess ConsiderationindecidingADRratio ~matchingofvalueof sharesofUScompaniesinthesameindustrybybundlinga specificno.ofsharesintooneADR Europeancompanies:72% AsianCompanies:21% LatinAmericaandAustralia:7% Top50ADRprogramsrepresented>90%oftradingvolumein 1999 NonUSfirmsraisingequityinUS Programmanagementdoneby Citibank,JPMorgan Othersimilarstructures GDR,EDR,IDR Accessmoreinvestors Broadershareholderbase Increasesliquidityofsharesandmakingitlessrisky Goodcorporategovernance filingUSGAAPaccounts, meetingcertainstandardsofcorporategovernance Increasedfirmsvaluation Crosslistedfirmshavehigherreturnsandalowercostof capital MaymakeafirmanditsproductsmorerecognizableinUS Maybeusefulasanacquisitioncurrency Easierforforeignfirmstocompeteformanagerialtalentsince theycanoffermanagersstockoptionsintheformofADRs Mayalsoincreaseexecutivepay universeofcomparable companiesbroadenstoUSandglobalfirmswhichusuallyhave higherlevelsofcompensation
142
PossibleAlternatives
US
Switzerland
3
Nestle
1
Alcon
Disadvantages Donoteliminatecurrencyrisk MaynotretainitsSwissidentity Requiresmoretransparencyin operationsandresults Maybecomeatakeovercandidate UnderminingNestles corporate cultureandprotectionitenjoysfrom takeover Activeinvestors:hedgefundsand specializedsectorfunds ListAlconinSwitzerlandandissue ADRinUS StillUSinvestorshaveanunderlying economicexposuretoUSD/CHF exchangerate
143
ADRMechanics
144
FactorsConsideredforIssuingADRs
Visibility Broader investorbase More sophisticated investorbase Acquisition currency
Accessto retailinvestors
Stockoptions foremployees
145
TypesofADRs
Level I Level II Level III Shares offered and listed on a US exchange AMEX NASDAQ NYSE Rule 144 A GDR Global offering of securities outside issuer's home market
Description
Unlisted
OTC market
Registered Registered Registered under under Form F-6 under Form F-6 forms F1 and F6 Exempt under Rule 12g3-2(b)
Form 20-F
Form 20-F
US private placement US exchange market Non US exchange Varies depending on structure of US None offering Varies depending on structure of US Exempt under rule offering 12g3-2(b)
Features
Can raise new capital No new capital Most eloborate form of ADR Most basic form can be issued Higer liquidty and Issuer cannot Financial raise capital statements need visibility Wide bid-ask to be prepared IPO type prospectus No SEC approval required spread as per US GAAP to be filed
146
Marketdisciplinefailsincase
Marketexpectations aboutpriceconvergence aretimeboundedand marketliquidityis limited
Differentmarket characteristics
Differentindex membership
Homebias
152
KeyCharacteristicsofAlternativeExit andRestructuringStrategies
174
ChoiceofRestructuringMethods Spinoffs
Parent'spotentialpositiontocreatevaluethroughskills,systems,orsynergiesisweak Parentsandsubsidiarieshaveconflictsofinterest
Equity carveouts
175